Lenalidomide plus dexamethasone is efficacious in patients with relapsed or refractory multiple myeloma

被引：2

作者：

Munshi, Nikhil C. ^{[1
,3
]}

Mitsiades, Constantine

Richardson, Paul G.

Anderson, Kenneth C. ^{[2
]}

机构：

[1] Dana Farber Canc Inst, Dept Med Oncol, Jerome Lipper Multiple Myeloma Ctr, Boston, MA 02115 USA

[2] Harvard Univ, Sch Med, Div Hematol Neoplasia, Boston, MA USA

[3] Boston VA Healthcare Syst, Boston, MA USA

来源：

NATURE CLINICAL PRACTICE ONCOLOGY | 2008年 / 5卷 / 07期

关键词：

dexamethasone; efficacy; lenalidomide; multiple myeloma; relapsed;

D O I：

10.1038/ncponc1151

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：374 / 375

页数：2

共 6 条

[1] Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets [J].

Hideshima, Teru ;

Mitsiades, Constantine ;

Tonon, Giovanni ;

Richardson, Paul G. ;

Anderson, Kenneth C. .

NATURE REVIEWS CANCER, 2007, 7 (08) :585-598

[2] Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma [J].

Palumbo, A. ;

Rajkumar, S. V. ;

Dimopoulos, M. A. ;

Richardson, P. G. ;

Miguel, J. San ;

Barlogie, B. ;

Harousseau, J. ;

Zonder, J. A. ;

Cavo, M. ;

Zangari, M. ;

Attal, M. ;

Belch, A. ;

Knop, S. ;

Joshua, D. ;

Sezer, O. ;

Ludwig, H. ;

Vesole, D. ;

Blade, J. ;

Kyle, R. ;

Westin, J. ;

Weber, D. ;

Bringhen, S. ;

Niesvizky, R. ;

Waage, A. ;

von Lilienfeld-Toal, M. ;

Lonial, S. ;

Morgan, G. J. ;

Orlowski, R. Z. ;

Shimizu, K. ;

Anderson, K. C. ;

Boccadoro, M. ;

Durie, B. G. ;

Sonneveld, P. ;

Hussein, M. A. .

LEUKEMIA, 2008, 22 (02) :414-423

[3] Melphalan, prednisone, and lenalidomide treatment for newly diagnosed myeloma:: A report from the GIMEMA -: Italian multiple myeloma network [J].

Palumbo, Antonio ;

Falco, Patrizia ;

Corradini, Paolo ;

Falcone, Antonietta ;

Di Raimondo, Francesco ;

Giuliani, Nicola ;

Crippa, Claudia ;

Ciccone, Giovannino ;

Omede, Paola ;

Ambrosini, Maria Teresa ;

Gay, Francesca ;

Bringhen, Sara ;

Musto, Pellegrino ;

Foa, Robin ;

Knight, Robert ;

Zeldis, Jerome B. ;

Boccadoro, Mario ;

Petrucci, Maria Teresa .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (28) :4459-4465

[4] A randomized trial of lenalidomide plus high-dose dexamethasone (RD) versus lenalidomide plus low-dose dexamethasone (Rd) in newly diagnosed multiple myeloma (E4A03): A trial coordinated by the eastern cooperative oncology group [J].

Rajkumar, S. Vincent ;

Jacobus, Susanna ;

Callander, Natalie ;

Fonseca, Rafael ;

Vesole, David ;

Williams, Michael ;

Abonour, Rafat ;

Siegel, David ;

Greipp, Philip .

BLOOD, 2007, 110 (11) :31A-31A

[5] Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myeloma [J].

Richardson, PG ;

Schlossman, RL ;

Weller, E ;

Hideshima, T ;

Mitsiades, C ;

Davies, F ;

LeBlanc, R ;

Catley, LP ;

Doss, D ;

Kelly, K ;

McKenney, M ;

Mechlowicz, J ;

Freeman, A ;

Deocampo, R ;

Rich, R ;

Ryoo, JJ ;

Chauhan, D ;

Balinski, K ;

Zeldis, J ;

Anderson, KC .

BLOOD, 2002, 100 (09) :3063-3067

[6] Lenalidomide plus dexamethasone for relapsed multiple myeloma in North America [J].

Weber, Donna M. ;

Chen, Christine ;

Niesvizky, Ruben ;

Wang, Michael ;

Belch, Andrew ;

Stadtmauer, Edward A. ;

Siegel, David ;

Borrello, Ivan ;

Rajkumar, S. Vincent ;

Chanan-Khan, Asher Alban ;

Lonial, Sagar ;

Yu, Zhinuan ;

Patin, John ;

Olesnyckyj, Marta ;

Zeldis, Jerome B. ;

Knight, Robert D. .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (21) :2133-2142

← 1 →